News
Servier to market Intarcia’s type 2 diabetes treatment outside...
France-based pharmaceutical research company Servier has partnered with Intarcia Therapeutics to develop and commercialise its ITCA 650, outside the US and Japan. ...
News
BMS’ sponsored programme selects four research projects to investigate...
Bristol-Myers Squibb's (BMS) European medical education programme Partnering for Cure has selected four research projects, designed to investigate new ways to cure viral diseases. ...
News
Felicitex Therapeutics and Selvita Initiate Strategic Collaboration to Target...
Cambridge, MA, USA and Krakow, Poland, November 7, 2014 / B3C newswire / -Felicitex Therapeutics, a leader in the diagnostics and development of therapeutics for...
News
LINDIS Biotech Consolidates Onco-Immune, Trifunctional, Bispecific Antibody IP and...
Munich, Germany, November 7, 2014 / B3C newswire / - Horst Lindhofer, CEO of LINDIS Biotech and inventor of the trifunctional antibody technology succeeded in...
News
Bristol-Myers Squibb expands biologics manufacturing agreement with Lonza
Bristol-Myers Squibb (BMS) has expanded its existing biologics manufacturing agreement with Switzerland-based Lonza. The contract is expanded for the production of...
News
ViiV Healthcare’s HIV drug Triumeq obtains Canadian approval
ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer and Shionogi, has obtained approval in Canada, for its Triumeq (dolutegravir) 50mg, abacavir 600mg,...
News
WHO warns of 10,000 new weekly Ebola cases
The World Health Organisation (WHO) has warned West Africa may face up to 10,000 new Ebola cases per week within two months, due to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.